Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
2.700
+0.130 (5.06%)
Aug 4, 2026, 3:23 PM EDT - Market open

Boundless Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
612765---
Market Cap Growth
133.57%-58.42%----
Enterprise Value
13.17-31.66-39.81000
Last Close Price
2.701.202.90---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
0.670.270.43---
P/TBV Ratio
0.700.270.33---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/EBITDA Ratio
-0.510.55---
EV/EBIT Ratio
-0.500.54---
EV/FCF Ratio
-0.670.63---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.520.460.3200.040
Net Debt / Equity Ratio
-0.52-0.59-0.690.930.751.90
Net Debt / EBITDA Ratio
0.750.941.452.201.352.95
Net Debt / FCF Ratio
0.941.241.652.501.512.87
Quick Ratio
9.698.5818.7012.908.6318.89
Current Ratio
9.878.7418.9813.278.8019.28
Return on Equity (ROE)
-60.52%-46.69%-48.21%-52.93%-52.16%-22.97%
Return on Assets (ROA)
-40.72%-34.97%-43.57%-53.01%-48.77%-22.25%
Return on Invested Capital (ROIC)
-121.07%-123.84%-244.61%-576.35%-183.47%-64.01%
Return on Capital Employed (ROCE)
-43.99%-37.08%-45.96%-57.79%-51.93%-23.03%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-0.64%-31.65%-1296.71%-10.75%-27.59%-
Total Shareholder Return
-0.64%-31.65%-1296.71%-10.75%-27.59%-
SEC Filings: 10-K · 10-Q